IMS Health (RX) is down $2.81 to $18.55 and options volume is 18X the average daily. Although there are no headlines on the company, Briefing notes that an AP article out last night said that, under a new proposal unveiled by two Senate Democrats, drug companies would no longer be able to mine records and track which doctors are prescribing their medications — link to story. IMS Health, Verispan and other companies have created a multi-million dollar industry gathering such data and selling it to pharmaceutical companies. IMS is taking a hit and it appears that sellers of Dec 20 calls are leading the flow. 6620 traded so far. Dec 17.5 puts, May 22.5 calls, and Dec 17.5 calls are busy as well. Huge spike in IV, to about 80, from 30 the day before.